Medicinal Cannabis prescriptions
This content has been automatically generated from the original PDF and some formatting may have been lost, therefore it should not be relied upon to extract citations or propose amendments. Please see the PDF for the official version of the document.
WQ.31/2026
WRITTEN QUESTION TO THE MINISTER FOR HEALTH AND SOCIAL SERVICES
BY DEPUTY D.J. WARR OF ST. HELIER SOUTH
QUESTION SUBMITTED ON MONDAY 9th FEBRUARY 2026
ANSWER TO BE TABLED ON MONDAY 16TH FEBRUARY 2026
Question
"Further to the increase in the number of medicinal cannabis prescriptions, as detailed in the response to Written Question 11/2026, will the Minister advise what controls, if any, exist to ensure that the level of prescription being dispensed is not subject to abuse; and, if no such controls exist, will he explain how he intends to resolve this matter?"
Answer
The majority of Cannabis-based products for medicinal use (CBPMs) supplied in Jersey are currently prescribed privately as unlicensed medicines. Although these products do not hold a marketing authorisation, they are not unregulated. Prescribing is undertaken only by registered healthcare professionals who are professionally and legally accountable for their clinical decisions and must comply with recognised professional standards.
Unlike some other jurisdictions, Jersey does not currently have in place legal controls on CBPM prescribing practice or an independent inspection regime. Officers are, however, actively developing proposed legal controls on prescribing practice with a view to consulting prescribers and patients over the Spring period.